Format

Send to

Choose Destination
Med Mycol. 2005 May;43 Suppl 1:S271-6.

Nuances of new anti-Aspergillus antifungals.

Author information

1
Duke University Medical Center, Durham, NC 27710, USA. perfe001@mc.duke.edu

Abstract

Invasive aspergillosis (IA) is a serious complication of immunosuppression, and has become more widespread as the immunocompromised population has increased as a result of new treatment strategies and diseases. This paper identifies and discusses seven issues for managing IA and combating drug resistance. Management of IA requires a multifactorial approach with the host as a major contributor to management strategies and outcome. However, significant progress has been made, and with careful use of the clinical tools available it is possible to make a successful impact on infection outcomes.

PMID:
16110820
DOI:
10.1080/13693780400020071
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center